Product is the top priority for pretty much every startup company, no matter what stage they are at. “Build a product users actually want” is common advice. Implementing it, however, can prove to be challenging (as many of you probably know.) Early stage companies sometimes lose direction, and some never ship. At a later stage, product roadmaps tend to get complex, and…
Notify Therapeutics, a biotech company based in Denmark, has raised €5M in funding to advance the development of its innovative non-hormonal fertility treatment. The investment was made by Lundbeckfonden BioCapital and +ND Capital, highlighting their continued commitment to boosting Danish biotech and addressing pressing fertility issues. Founded from research by Professor Karin Lykke-Hartmann into female infertility, Notify Therapeutics is at the forefront…
A new report by Carrot Fertility recently found that menopause is significantly impacting women’s careers with 80% citing it as a workplace challenge. The report, titled ‘2023 Menopause in the Workplace’, highlights the evident stigma and ageism related to battling menopause in the workplace. About 72% of the women reported feeling uncomfortable after experiencing menopause symptoms at work, and nearly 50% reported…
Blue Cross and Blue Shield of Texas (BCBSTX) has announced a significant $1.2M grant to establish the first March of Dimes Mom & Baby Mobile Health Center in Texas. Targeted to launch by fall 2024, this Houston-based initiative marks a major effort to improve maternal and infant health outcomes statewide. The mobile health center will partner with clinical providers to offer crucial…
age1, a venture capital firm specializing in longevity biotech, launched earlier this week in San Francisco announcing an initial closing fund of $35M. The firm aims to radically shift the paradigm from sick care to health preservation and lifespan extension. Backed by a specialized team with a track record, age1 was co-founded by Laura Deming, founder of The Longevity Fund, and Dr.…
In a stride forward for women’s health and cervical cancer prevention, Asieris Pharmaceuticals has declared the successful completion of its Phase III clinical trial for APL-1702 (Cevira), a non-surgical treatment aimed at cervical high-grade squamous intraepithelial lesions (HSIL). This significant milestone could shift the paradigm in treating this precancerous condition, offering a less invasive alternative to surgery, and may particularly benefit women…
Two years after its $5.8M seed round, Los Angeles-based perinatal nutrition and education startup Needed has secured an additional $14.6M in funding. Fitt Insider reports the news, citing Street Insider as its source. This latest infusion of capital comes as a strong vote of confidence in the company’s mission to address the gaps in maternal nutrition and education. A Recap of the…
Highlights GE HealthCare secures a $44M Grant to Develop AI-Assisted Ultrasound Technology for Maternal and Pediatric Care. Leone Solutions Group raises $3.3M in pre-seed funding for CLEONA, an AI-powered tool for maternal health. Blooming Health secures $4.2M in seed funding to transform aging-in-place through tech. Equip extends its virtual eating disorder treatment to adults; raises undisclosed amount from General Catalyst. Natural Cycles gains FDA Clearance for its Apple Watch Integration. Gedeon Richter and Sumitomo Pharma receive CHMP approval for endometriosis…
A recent study published in the Nature demonstrates the potential of CHLOE, an AI decision support technology developed by Fairtility, to advance academic research in reproductive health. The study led by Professor Iris Har Vardi, an authority in the field of fertility and IVF, specifically focused on the impact of blastocyst morphometric parameters on implantation potential. Professor Har Vardi, Director of Fertility…
